Your session is about to expire
← Back to Search
Liposomal Bupivacaine vs Lidocaine for Skin Graft Pain
Study Summary
This trialcompares how well different anesthetics reduce pain and opioid use after skin grafts for partial or full thickness burns.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Burns on the front of the thighs.You have less than 20% of your body surface area burned, with less than 5% of that being deep burns.You have a long-lasting pain condition.You have burns covering more than 20% of your total body surface area, or more than 5% of your body has deep burns.You are allergic to lidocaine or other numbing medicines.
- Group 1: Group 1
- Group 2: Group 3
- Group 3: Group 2
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What primary ailments can Group 1 be applied to?
"Group 1 treatments are frequently used to treat minor burns, but they can also provide relief from lupus erythematosus cell, ulcerative colitis and transplantation."
What security measures can be taken to ensure Group 1 is not a hazard for people?
"As this is a phase 4 trial, which signals a treatment's approval, our team at Power gave Group 1 an assessment of 3 on the safety scale."
How many volunteers are currently partaking in this clinical experiment?
"Indeed. According to clinicaltrials.gov, this study posted on March 18th 2019 is still enrolling patients and was recently updated on December 28th 2022. 75 participants are needed at the single site hosting the trial."
Are there still open slots available for this research endeavor?
"Affirmative. Clinicaltrials.gov indicates that this investigation, which was published on March 18th 2019, is currently seeking participants. An estimated 75 people need to be enrolled from 1 center of care."
What further research has been conducted concerning Group 1?
"At present, 40 trials for Group 1 are in the third phase of development. Furthermore, 192 active studies exist within this group and 1203 locations across Germantown, Tennessee have been conducting these tests."
Share this study with friends
Copy Link
Messenger